RA
Rise Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
1,403
+20
| +1% | +$3.71K | 0.1% | 76 |
|
|
2025
Q1 | $290K | Buy |
1,383
+95
| +7% | +$19.9K | 0.13% | 70 |
|
|
2024
Q4 | $229K | Buy |
1,288
+21
| +2% | +$3.73K | 0.11% | 78 |
|
|
2024
Q3 | $250K | Buy |
1,267
+10
| +0.8% | +$1.98K | 0.12% | 75 |
|
|
2024
Q2 | $216K | Buy |
1,257
+24
| +2% | +$4.12K | 0.11% | 87 |
|
|
2024
Q1 | $225K | Buy |
1,233
+933
| +311% | +$170K | 0.12% | 82 |
|
|
2023
Q4 | $46.6K | Sell |
300
-22
| -7% | -$3.42K | 0.03% | 165 |
|
|
2023
Q3 | $47.9K | Sell |
322
-2,204
| -87% | -$328K | 0.04% | 143 |
|
|
2023
Q2 | $340K | Sell |
2,526
-102
| -4% | -$13.7K | 0.26% | 42 |
|
|
2023
Q1 | $419K | Buy |
2,628
+6
| +0.2% | +$956 | 0.32% | 37 |
|
|
2022
Q4 | $424K | Buy |
2,622
+2
| +0.1% | +$323 | 0.34% | 37 |
|
|
2022
Q3 | $352K | Buy |
2,620
+3
| +0.1% | +$403 | 0.29% | 42 |
|
|
2022
Q2 | $401K | Buy |
2,617
+61
| +2% | +$9.35K | 0.4% | 36 |
|
|
2022
Q1 | $414K | Sell |
2,556
-233
| -8% | -$37.7K | 0.37% | 37 |
|
|
2021
Q4 | $378K | Buy |
+2,789
| New | +$378K | 0.36% | 41 |
|